Marvell Technology Group Ltd

MRVL

$61.03

+33.2% (1 year change)

Market Cap

$52.1 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$40.79 - $64.07

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

-140.39x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.06 (0.09%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $52.1 Billion
Enterprise Value $56.5 Billion
Dividend Yield $0.06 (0.09%)
1 Year Return +33.3%
52-Week High $64.07
52-Week Low $40.79
Beta 0.0
Outstanding Shares 824 Million
Avg 30 Day Volume 5.22 Million

Valuation

P/E Ratio -140.39
PEG -
Earnings per Share -$0.52
Price to Sales Ratio -
Price to Book Ratio 3.39
Revenue to Enterprise Value -
EBIT to Enterprise Value -
Total Debt to Enterprise Value 0.09
Debt to Equity 0.33

Profitability

Revenue -
Gross Profit -
EBIT -
Net Income -
Profit Margin -
Quarterly Earnings Growth (YoY) -
Return on Equity -
Return on Assets -
Return on Invested Capital -

News

Marvell man sentenced in Fayetteville for drugs, gun

Marvell man sentenced in Fayetteville for drugs, gun

A Marvell man was sentenced Friday to 108 months in federal prison followed by three years of supervised release on one count of distribution of a controlled substance, cocaine, and one count of us...

Northwest Arkansas Democrat-Gazette Northwest Arkansas Democrat-Gazette, 1 day ago
Marvel Biosciences Corp. to Present at the 22nd International Conference on Alzheimer''s Drug Discovery

Marvel Biosciences Corp. to Present at the 22nd International Conference on Alzheimer''s Drug Discovery

Calgary, Alberta--(Newsfile Corp. - September 17, 2021) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"),

FinanzNachrichten FinanzNachrichten, 6 days ago
G.Fast Chipset Market 2020 key players  Qualcomm, Broadcom, Marvell Technology, Mediatek, Sckipio Technologies Si

G.Fast Chipset Market 2020 key players Qualcomm, Broadcom, Marvell Technology, Mediatek, Sckipio Technologies Si

G.Fast Chipset Market forecast to 2027 The Global G.Fast Chipset Market report provides information about the Global industry, including valuable facts and figures. This research study explores the...

Cheshire Media Cheshire Media, 9 days ago